A citation-based method for searching scientific literature

Xiaotian Yuan, Mingkai Dai, Dawei Xu. Curr Top Med Chem 2020
Times Cited: 12







List of co-cited articles
74 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.
Jenny Dahlström, Tiantian Liu, Xiaotian Yuan, Leonie Saft, Mehran Ghaderi, Ya Bin Wei, Catharina Lavebratt, Ping Li, Chengyun Zheng, Magnus Björkholm,[...]. Ann Hematol 2016
17
41

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Xiaotian Yuan, Guanghui Cheng, Jingya Yu, Shunzhen Zheng, Chao Sun, Qing Sun, Kailin Li, Zhaomin Lin, Tiantian Liu, Ping Li,[...]. Oncotarget 2017
19
33

Longitudinal changes in leukocyte telomere length and mortality in elderly Swedish men.
Xiaotian Yuan, Magnus Kronström, Mai-Lis Hellenius, Tommy Cederholm, Dawei Xu, Per Sjögren. Aging (Albany NY) 2018
14
33

Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Z Liu, Q Li, K Li, L Chen, W Li, M Hou, T Liu, J Yang, C Lindvall, M Björkholm,[...]. Oncogene 2013
173
33

Telomere measurement by quantitative PCR.
Richard M Cawthon. Nucleic Acids Res 2002
33

MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia.
Xiaolu Zhang, Bingnan Li, Jingya Yu, Jenny Dahlström, Anh Nhi Tran, Magnus Björkholm, Dawei Xu. Ann Hematol 2018
13
25

Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease.
Cécilia G Maubaret, Klelia D Salpea, Casey E Romanoski, Lasse Folkersen, Jackie A Cooper, Coralea Stephanou, Ka Wah Li, Jutta Palmen, Anders Hamsten, Andrew Neil,[...]. PLoS One 2013
35
25

Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimers disease.
D Scarabino, E Broggio, G Gambina, F Pelliccia, R M Corbo. Exp Gerontol 2017
14
25

Telomere diseases.
Rodrigo T Calado, Neal S Young. N Engl J Med 2009
503
25

Genetic variation in TERT and TERC and human leukocyte telomere length and longevity: a cross-sectional and longitudinal analysis.
Mette Soerensen, Mikael Thinggaard, Marianne Nygaard, Serena Dato, Qihua Tan, Jacob Hjelmborg, Karen Andersen-Ranberg, Tinna Stevnsner, Vilhelm A Bohr, Masayuki Kimura,[...]. Aging Cell 2012
72
25

Telomerase insufficiency in rheumatoid arthritis.
Hiroshi Fujii, Lan Shao, Inés Colmegna, Jörg J Goronzy, Cornelia M Weyand. Proc Natl Acad Sci U S A 2009
121
25

Common variants near TERC are associated with mean telomere length.
Veryan Codd, Massimo Mangino, Pim van der Harst, Peter S Braund, Michael Kaiser, Alan J Beveridge, Suzanne Rafelt, Jasbir Moore, Chris Nelson, Nicole Soranzo,[...]. Nat Genet 2010
231
25

Association Between the Telomerase rs2736098_TT Genotype and a Lower Risk of Chronic Hepatitis B and Cirrhosis in Chinese Males.
Guanghui Cheng, Xiaotian Yuan, Fang Wang, Qing Sun, Qian Xin, Kailin Li, Chao Sun, Zhaomin Lin, Yun Luan, Yiteng Xu,[...]. Clin Transl Gastroenterol 2017
8
37


Common variants near TERC are associated with leukocyte telomere length in the Chinese Han population.
Qin Shen, Zhou Zhang, Lan Yu, Lan Cao, DaiZhan Zhou, MengYuan Kan, Baojie Li, Di Zhang, Lin He, Yun Liu. Eur J Hum Genet 2011
45
25

GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Yanxia Guo, Xiaotian Yuan, Kailin Li, Mingkai Dai, Lu Zhang, Yujiao Wu, Chao Sun, Yuan Chen, Guanghui Cheng, Cheng Liu,[...]. Cell Death Differ 2020
13
25

Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Jingya Yu, Xiaotian Yuan, Louise Sjöholm, Tiantian Liu, Feng Kong, Tomas J Ekström, Magnus Björkholm, Dawei Xu. Cancer Lett 2018
23
25

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
287
25

TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR.
Kun Wang, Tiantian Liu, Nan Ge, Li Liu, Xiaotian Yuan, Jikai Liu, Feng Kong, Chang Wang, Hongbo Ren, Keqiang Yan,[...]. Oncotarget 2014
41
25

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
157
25

Telomeres, Telomerase and Ageing.
Gabriele Saretzki. Subcell Biochem 2018
26
25

Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.
Md Ismail Hosen, Mahdi Sheikh, Maria Zvereva, Ghislaine Scelo, Nathalie Forey, Geoffroy Durand, Catherine Voegele, Hossein Poustchi, Masoud Khoshnia, Gholamreza Roshandel,[...]. EBioMedicine 2020
13
25


Telomerase modulates Wnt signalling by association with target gene chromatin.
Jae-Il Park, Andrew S Venteicher, Ji Yeon Hong, Jinkuk Choi, Sohee Jun, Marina Shkreli, Woody Chang, Zhaojing Meng, Peggie Cheung, Hong Ji,[...]. Nature 2009
432
16

Genetic variants within telomere-associated genes, leukocyte telomere length and the risk of acute coronary syndrome in Czech women.
Dana Dlouha, Jan Pitha, Jana Mesanyova, Jolana Mrazkova, Adela Fellnerova, Vladimir Stanek, Vera Lanska, Jaroslav A Hubacek. Clin Chim Acta 2016
6
33

Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.
Clare Turnbull, Elizabeth A Rapley, Sheila Seal, David Pernet, Anthony Renwick, Deborah Hughes, Michelle Ricketts, Rachel Linger, Jeremie Nsengimana, Panagiotis Deloukas,[...]. Nat Genet 2010
254
16



Telomeres and immune competency.
Nan-ping Weng. Curr Opin Immunol 2012
43
16

Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Xinyu Ci, Bingnan Li, Xueping Ma, Feng Kong, Chengyun Zheng, Magnus Björkholm, Jihui Jia, Dawei Xu. Oncotarget 2015
16
16

Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.
Simone Mocellin, Daunia Verdi, Karen A Pooley, Maria T Landi, Kathleen M Egan, Duncan M Baird, Jennifer Prescott, Immaculata De Vivo, Donato Nitti. J Natl Cancer Inst 2012
102
16

Regulation of the human catalytic subunit of telomerase (hTERT).
Michael Daniel, Gregory W Peek, Trygve O Tollefsbol. Gene 2012
170
16

Premature senescence of T-cell subsets in axial spondyloarthritis.
Johannes Fessler, Andrea Raicht, Rusmir Husic, Anja Ficjan, Christina Duftner, Wolfgang Schwinger, Christian Dejaco, Michael Schirmer. Ann Rheum Dis 2016
20
16

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
171
16

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
73
16

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Martin Hysek, Johan O Paulsson, Kenbugul Jatta, Ivan Shabo, Adam Stenman, Anders Höög, Catharina Larsson, Jan Zedenius, Carl Christofer Juhlin. Cancers (Basel) 2019
18
16

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
97
16

TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
Kun Wang, Tiantian Liu, Cheng Liu, Yan Meng, Xiaotian Yuan, Li Liu, Nan Ge, Jikai Liu, Chang Wang, Hongbo Ren,[...]. Oncologist 2015
21
16

WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERThigh Prostate Cancer Stem Cells.
Kai Zhang, Yanjing Guo, Xue Wang, Huifang Zhao, Zhongzhong Ji, Chaping Cheng, Li Li, Yuxiang Fang, Dawei Xu, Helen He Zhu,[...]. Cancer Res 2017
72
16


JAK2 inhibition in JAK2V617F-bearing leukemia cells enriches CD34+ leukemic stem cells that are abolished by the telomerase inhibitor GRN163L.
Jenny Dahlström, Chuanyou Xia, Xiangling Xing, Xiaotian Yuan, Magnus Björkholm, Dawei Xu. Biochem Biophys Res Commun 2020
4
50

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Xiaotian Yuan, Ninni Mu, Na Wang, Klas Strååt, Anastasios Sofiadis, Yanxia Guo, Adam Stenman, Kailin Li, Guanghui Cheng, Lu Zhang,[...]. Oncogene 2019
21
16

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
77
16

Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations.
Lindley Maryoung, Yangbo Yue, Ashley Young, Chad A Newton, Cindy Barba, Nicolai S C van Oers, Richard C Wang, Christine Kim Garcia. J Clin Invest 2017
28
16

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
16

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
16

Programmable base editing of mutated TERT promoter inhibits brain tumour growth.
Xinjian Li, Xu Qian, Bin Wang, Yan Xia, Yanhua Zheng, Linyong Du, Daqian Xu, Dongming Xing, Ronald A DePinho, Zhimin Lu. Nat Cell Biol 2020
21
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.